İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

FEYZİ SİNAN TOKALI

DOÇENT

KAFKAS ÜNİVERSİTESİ KARS MESLEK YÜKSEKOKULU MALZEME VE MALZEME İŞLEME TEKNOLOJİLERİ BÖLÜMÜ

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Kimya
Makale 67 YÖKSİS · 67 OpenAlex · 0
Proje 18
Kitap 0
Bildiri 9

Yayın sayısı iki kaynaktan gelir ve her kaynak ayrı gösterilir: YÖKSİS (akademisyen beyanı) ve OpenAlex (açık akademik katalog). Patent ve sanatsal etkinlikler aşağıdaki Çalışmalar sekmelerinde yer alır.

Araştırma konuları

OpenAlex

Dizin çeyrekleri

Scopus (SJR)

66 Toplam

  • Q1 16
  • Q2 34
  • Q3 16
  • Q4 2
Diğer sayımlar
  • En iyi Q 66 Q1 16 Q2 32 Q3 16 Q4 2
  • YÖKSİS satırı 68 Q1 0 Q2 0 Q3 0 Q4 0

WoS (JCR)

64 Toplam

  • Q1 15
  • Q2 26
  • Q3 25
  • Q4 0
Diğer sayımlar
  • En iyi Q 64 Q1 15 Q2 24 Q3 25 Q4 0
  • YÖKSİS satırı 66 Q1 0 Q2 0 Q3 0 Q4 0

TR Index

2 makale

OpenAlex atıf yüzdelikleri

Üst %1 makale 12
Üst %10 makale 49
Ort. yüzdelik 87.5%
Yüzdelikli makale 68

OpenAlex atıf yüzdeliği; kapsanan yayınlar (~%52).

Bu göstergeler ne anlama geliyor?
  • Q1–Q4: Yayının çıktığı derginin ilgili indeksteki (Scopus/WoS) çeyrek dilimi. Q1 en üst %25, Q4 en alt %25.
  • Üst %1 / üst %10: Aynı alan ve yılda, dünyada en çok atıf alan %1 veya %10 içindeki yayın sayısı.
  • Ort. yüzdelik: Yayınların atıf persentillerinin ortalaması (100 = en üst).
  • Kaynak: indeks çeyrekleri Scopus/WoS ve TR Index bayrakları; atıf persentilleri OpenAlex.

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

29 dergi
Scopus (SJR)
Q1 16 Q2 34 Q3 16 Q4 2
WoS (JCR)
Q1 15 Q2 26 Q3 25 Q4 0
TR Index
2 makale

Makale listesi

  1. 2026 New quinazolinone-thiazolidinedione hybrids as selective anti-lung cancer agents and promising EGFR inhibitors Future Medicinal Chemistry DOI 10.1080/17568919.2026.2620368 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 98.8%
  2. 2026 Rational design of phenyl 2,4,5-trichlorobenzenesulfonate based thiosemicarbazones as α-glucosidase and α-amylase inhibitors: integrating enzymatic evaluation and molecular modeling RSC Advances DOI 10.1039/D5RA08761A YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %1 OpenAlex 99.6%
  3. 2026 Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer’s key enzymes: From synthesis to inhibition Computational Biology and Chemistry DOI 10.1016/j.compbiolchem.2025.108683 YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %1 OpenAlex 99.8%
  4. 2026 Design, synthesis, and multitarget evaluation of thiosemicarbazone–sulfonamide hybrids as potent cholinesterase and MAO-A inhibitors with neuroblastoma-associated cytotoxicity Scientific Reports DOI 10.1038/s41598-026-52909-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 92.0%
  5. 2026 Design and Synthesis of Polymethoxy Rhodanines as Selective Small-Molecule Candidates for Breast Cancers Journal of Molecular Structure DOI 10.1016/j.molstruc.2026.145703 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 98.7%
  6. 2026 Design and synthesis of new thienopyrimidine derivatives as potential anticancer agents: From cytotoxicity screening to VEGFR inhibition modeling Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.144425 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 98.3%
  7. 2026 Rational design of thiazolidine-2,4-dione-integrated combretastatin A-4 analogues as potent and selective tubulin-targeting agents for triple-negative breast cancer European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2026.119270 YÖKSİS SJR Q1 JCR Q1 OpenAlex 84.3%
  8. 2026 C5-Arylidene Rhodanine Scaffolds from L-Phenylalanine and Core Structures: Synthesis and Anticancer Evaluation Journal of Molecular Structure DOI 10.1016/j.molstruc.2026.145520 YÖKSİS SJR Q2 JCR Q2 OpenAlex 84.3%
  9. 2026 Harnessing natures building blocks: potent and safe urease inhibition by simple amino acids Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.109419 YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.5%
  10. 2026 Identification of selective N-pyridinsulfonyl indole based thiosemicarbazone derivatives as potential antiproliferative agents against lung cancer cells RSC Advances DOI 10.1039/d6ra02731h YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.3%
  11. 2026 4-(2,4-dichlorobenzamido)-benzohydrazide derivatives and their elastic liposomal formulations for cholinesterase and neuroblastoma inhibition: A comprehensive in vitro and in silico study Journal of Molecular Structure DOI 10.1016/j.molstruc.2026.146575 YÖKSİS SJR Q2 JCR Q2 OpenAlex 47.5%
  12. 2026 Development of new thiosemicarbazones with strong α-glucosidase and antioxidant action Future Medicinal Chemistry DOI 10.1080/17568919.2026.2675874 YÖKSİS SJR Q3 JCR Q3 OpenAlex 43.2%
  13. 2026 Targeting cholinergic dysfunction and neuroinflammation through rationally designed Thieno[3,2-d]pyrimidine hybrids Bioorganic Chemistry DOI 10.1016/j.bioorg.2026.109778 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.9%
  14. 2026 Development of novel diaryl ether–phenolic Mannich Base derivatives with potent cholinesterase inhibition and low neuronal toxicity Bioorganic Chemistry DOI 10.1016/j.bioorg.2026.110354 YÖKSİS SJR Q1 JCR Q1 OpenAlex 83.5%
  15. 2026 New Thieno[3,2-d]Pyrimidin-4(3H)-One Schiff Bases as Selective Antileishmanial Agents Life DOI 10.3390/life16060979 YÖKSİS SJR Q1 JCR Q1 OpenAlex 60.4%
  16. 2026 Synthesis, multi-target evaluation and DFT analysis of 6-hydroxychromone derived hydrazones with carbonic anhydrase I–II/acetylcholinesterase inhibition and antioxidant activity RSC Advances DOI 10.1039/d5ra10080a YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %1 OpenAlex 99.7%
  17. 2026 Design, Synthesis, and Biological Evaluation of Biphenylsulfonyl Indole‐Based Thiosemicarbazones as Potential AChE and CA I‐II Inhibitors Archiv der Pharmazie DOI 10.1002/ardp.70315 YÖKSİS SJR Q2 JCR Q2 OpenAlex 80.8%
  18. 2026 2,3-Dihydroquinazolin-4(1H)-one derivatives as potent aldose reductase inhibitors: a combined experimental and computational study Bioorganic Chemistry DOI 10.1016/j.bioorg.2026.110081 YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.6%
  19. 2025 Novel thiazolidinedione hybrids as cholinesterase inhibitors and targeting neuroblastoma: design, synthesis, in vitro and in silico biological evaluations Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.108869 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.4%
  20. 2025 Design, Synthesis, and Evaluation of Novel Quinazolin-4(3H)-One Derivatives: Anti-Leishmanial Activity, Selectivity, and Molecular Docking Insights Journal of Biochemical and Molecular Toxicology DOI 10.1002/jbt.70309 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 92.8%

Akademisyenlere dön